155 related articles for article (PubMed ID: 37011526)
21. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs.
Sake JK; Hebert D; Isojärvi J; Doty P; De Backer M; Davies K; Eggert-Formella A; Zackheim J
CNS Drugs; 2010 Dec; 24(12):1055-68. PubMed ID: 21090839
[TBL] [Abstract][Full Text] [Related]
22. Efficacy, safety, and tolerability of adjunctive perampanel in patients from China with focal seizures or generalized tonic-clonic seizures: Post hoc analysis of phase III double-blind and open-label extension studies.
Weiping L; Dong Z; Zhen H; Patten A; Dash A; Malhotra M
CNS Neurosci Ther; 2021 Mar; 27(3):330-340. PubMed ID: 33340263
[TBL] [Abstract][Full Text] [Related]
23. Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures.
Brandt C; Dimova S; Elmoufti S; Laloyaux C; Nondonfaz X; Klein P
Epilepsy Behav; 2023 Jan; 138():108967. PubMed ID: 36435010
[TBL] [Abstract][Full Text] [Related]
24. CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development.
Demarest ST; Olson HE; Moss A; Pestana-Knight E; Zhang X; Parikh S; Swanson LC; Riley KD; Bazin GA; Angione K; Niestroj LM; Lal D; Juarez-Colunga E; Benke TA
Epilepsia; 2019 Aug; 60(8):1733-1742. PubMed ID: 31313283
[TBL] [Abstract][Full Text] [Related]
25. Long-term safety and efficacy of brivaracetam in adults with focal seizures: Results from an open-label, multinational, follow-up trial.
Arnold S; Laloyaux C; Schulz AL; Elmoufti S; Yates S; Fakhoury T
Epilepsy Res; 2020 Oct; 166():106404. PubMed ID: 32731118
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of eslicarbazepine acetate as a first or later adjunctive therapy in patients with focal seizures.
Hixson J; Gidal B; Pikalov A; Zhang Y; Mehta D; Blum D; Cantu D; Grinnell T;
Epilepsy Res; 2021 Mar; 171():106561. PubMed ID: 33556737
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics, pharmacodynamics and safety assessment of multiple doses of soticlestat in healthy volunteers.
Wang S; Chen G; Merlo Pich E; Affinito J; Cwik M; Faessel HM
Br J Clin Pharmacol; 2022 Jun; 88(6):2899-2908. PubMed ID: 35001412
[TBL] [Abstract][Full Text] [Related]
28. A survey of seizures and current treatments in 15q duplication syndrome.
Conant KD; Finucane B; Cleary N; Martin A; Muss C; Delany M; Murphy EK; Rabe O; Luchsinger K; Spence SJ; Schanen C; Devinsky O; Cook EH; LaSalle J; Reiter LT; Thibert RL
Epilepsia; 2014 Mar; 55(3):396-402. PubMed ID: 24502430
[TBL] [Abstract][Full Text] [Related]
29. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of adjunctive antiseizure medications for dravet syndrome: A systematic review and network meta-analysis.
Wu J; Zhang L; Zhou X; Wang J; Zheng X; Hu H; Wu D
Front Pharmacol; 2022; 13():980937. PubMed ID: 36120377
[No Abstract] [Full Text] [Related]
31. Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: a phase IIb, randomized, controlled trial.
Van Paesschen W; Hirsch E; Johnson M; Falter U; von Rosenstiel P
Epilepsia; 2013 Jan; 54(1):89-97. PubMed ID: 22813235
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of perampanel in patients with drug-resistant partial seizures after conversion from double-blind placebo to open-label perampanel.
Montouris G; Yang H; Williams B; Zhou S; Laurenza A; Fain R
Epilepsy Res; 2015 Aug; 114():131-40. PubMed ID: 26088896
[TBL] [Abstract][Full Text] [Related]
33. Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures.
Chung S; Sinha SR; Shah A; Stern JM; Cheng H; Jung J; Grinnell T; Blum D
Epilepsy Res; 2019 Jul; 153():59-65. PubMed ID: 30999260
[TBL] [Abstract][Full Text] [Related]
34. Anticonvulsive properties of soticlestat, a novel cholesterol 24-hydroxylase inhibitor.
Nishi T; Metcalf CS; Fujimoto S; Hasegawa S; Miyamoto M; Sunahara E; Watanabe S; Kondo S; White HS
Epilepsia; 2022 Jun; 63(6):1580-1590. PubMed ID: 35316533
[TBL] [Abstract][Full Text] [Related]
35. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial.
Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P
Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628
[TBL] [Abstract][Full Text] [Related]
36. Safety, tolerability, and efficacy of brivaracetam as adjunctive therapy in patients with focal seizures, generalized onset seizures, or Unverricht-Lundborg disease: An open-label, long-term follow-up trial.
Ben-Menachem E; Baulac M; Hong SB; Cleveland JM; Reichel C; Schulz AL; Wagener G; Brandt C
Epilepsy Res; 2021 Feb; 170():106526. PubMed ID: 33461041
[TBL] [Abstract][Full Text] [Related]
37. Ataluren for drug-resistant epilepsy in nonsense variant-mediated Dravet syndrome and CDKL5 deficiency disorder.
Devinsky O; King L; Bluvstein J; Friedman D
Ann Clin Transl Neurol; 2021 Mar; 8(3):639-644. PubMed ID: 33538404
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the long-term efficacy and safety of adjunctive perampanel in tonic-clonic seizures: Analysis of four open-label extension studies.
Rektor I; Krauss GL; Inoue Y; Kaneko S; Williams B; Patten A; Malhotra M; Laurenza A; Wechsler RT
Epilepsia; 2020 Jul; 61(7):1491-1502. PubMed ID: 32645213
[TBL] [Abstract][Full Text] [Related]
39. Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years.
Conry JA; Ng YT; Kernitsky L; Mitchell WG; Veidemanis R; Drummond R; Isojarvi J; Lee D; Paolicchi JM;
Epilepsia; 2014 Apr; 55(4):558-67. PubMed ID: 24580023
[TBL] [Abstract][Full Text] [Related]
40. Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study.
Nishida T; Lee SK; Inoue Y; Saeki K; Ishikawa K; Kaneko S
Acta Neurol Scand; 2018 Apr; 137(4):392-399. PubMed ID: 29250772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
